Cervical Length Ultrasound: Complete Preterm Birth Risk Guide

Cervical length measurement via transvaginal ultrasound between 18-24 weeks gestation is a highly effective screening tool for identifying women at increased risk of spontaneous preterm birth. A normal cervical length is > 25 mm, with measurements between 25-30 mm considered borderline. Cervical length < 25 mm, particularly < 15 mm, is associated with significantly increased risk of spontaneous preterm birth. For women with a short cervix (< 20 mm) and no prior preterm birth, vaginal progesterone supplementation reduces preterm birth rates by approximately 40-45%. For women with a prior spontaneous preterm birth and cervical length < 25 mm, cervical cerclage (placement of a stitch around the cervix) reduces recurrent preterm birth by approximately 30-40%. Universal cervical length screening of all pregnant women between 18-24 weeks is recommended by ACOG, with serial measurements every 2-4 weeks indicated for women with risk factors or borderline measurements. The examination is performed transvaginally, takes approximately 2-3 minutes, causes minimal discomfort, and has become standard of care in preterm birth prevention strategies.

Normal Cervical Structure

The cervix is the lower portion of the uterus that connects the uterine cavity to the vagina:

Anatomical Components:

• Ectocervix: Portion visible on speculum examination
• Endocervical canal: Connects the uterine cavity to the vagina
• Internal os: Opening into the uterine cavity
• External os: Opening into the vagina
• Cervical stroma: Fibrous connective tissue providing structural support

Normal Cervical Physiology:

• Early pregnancy: Cervix remains long and closed
• Second trimester: Cervix begins to shorten gradually
• Late pregnancy: Progressive shortening occurs
• Labor: Rapid shortening and dilation occur

Cervical Remodeling

The cervix undergoes characteristic changes before spontaneous preterm birth:

Normal Cervical Remodeling (Term):

• Gradual shortening: Slow, progressive decrease in length
• Softening: Cervical consistency becomes softer
• Effacement: Thinning of cervical tissue
• Dilation: Opening of cervical os

Preterm Cervical Remodeling:

• Premature shortening: Cervix shortens before 37 weeks
• Funneling: Internal os opens with normal length of external segment
• Hourglass appearance: Wide internal opening, narrow external opening
• Rapid changes: Changes occur more quickly than at term

Measurement Technique

Transvaginal ultrasound is the standard method for cervical length assessment:

Procedure:

1. Patient preparation: Empty bladder (full bladder can falsely elongate cervix)
2. Patient position: Supine with hips flexed, knees bent (lithotomy position)
3. Transducer insertion: Vaginal probe inserted gently
4. Imaging: Sagittal view of cervix obtained
5. Measurement: Length of closed endocervical canal from internal to external os
6. Pressure: Minimal pressure applied to avoid falsely lengthening cervix

Technical Requirements:

• Sagittal view: True midline sagittal plane
• Full length: Entire endocervical canal must be visible
• Closed canal: Measurement of closed portion only
• Clear landmarks: Internal os, external os, endocervical canal clearly visualized
• Minimal pressure: Excessive pressure can elongate the cervix
• Three measurements: Typically obtain three measurements and use the shortest

Measurement Landmarks:

• Internal os: Junction between uterine cavity and endocervical canal
  • Appearance: Triangular notch or "V" shape
  • Surrounded by: Uterine muscle superiorly, cervical stroma inferiorly
• External os: Junction between endocervical canal and vagina
  • Appearance: Rounded or triangular opening
  • Surrounded by: Vaginal fornices

Normal and Abnormal Values

Cervical Length Categories:

Gestational Age-Specific Values:

Universal Screening

ACOG recommends universal cervical length screening:

Recommendation:

• Timing: 18-24 weeks gestation (optimal: 20-22 weeks)
• Method: Transvaginal ultrasound
• Population: All pregnant women regardless of risk status
• Frequency: Single measurement, with repeat if short or borderline

Rationale for Universal Screening:

• Majority of preterm births: Occur in women without prior preterm birth
• Effective intervention: Progesterone and cerclage are effective when short cervix identified
• Cost-effective: Screening and treatment are cost-effective compared to cost of preterm birth care
• Non-invasive: Quick, well-tolerated examination

Targeted Screening (High-Risk Women)

Women with specific risk factors may benefit from earlier and more frequent screening:

Indications for Targeted Screening:

Normal Cervical Length (> 30 mm)

Management:

• Routine prenatal care: No additional interventions indicated
• Standard surveillance: Routine prenatal visits
• Reassurance: Low risk of spontaneous preterm birth

Borderline Cervical Length (25-30 mm)

Management:

• Repeat measurement: In 2-4 weeks to assess for change
• Risk factor assessment: Evaluate for other risk factors
• Patient education: Signs and symptoms of preterm labor
• Increased awareness: May warrant increased vigilance

Factors Influencing Management:

• Gestational age: Earlier gestation more concerning
• Trend over time: Stable vs. decreasing length
• Other risk factors: Presence of other preterm birth risk factors
• Patient history: Prior preterm birth, cervical surgery

Short Cervical Length (< 25 mm)

Management depends on prior obstetric history:

No Prior Spontaneous Preterm Birth:

• Vaginal progesterone: First-line treatment
  • Dose: 200 mg daily (micronized progesterone)
  • Duration: Continue until 36-37 weeks
  • Efficacy: Reduces PTB < 34 weeks by 40-45%
  • Route: Vaginal suppository or gel

Prior Spontaneous Preterm Birth:

• Cervical cerclage: First-line treatment for cervical length < 25 mm
  • Procedure: Stitch placed around cervix at 12-24 weeks
  • Timing: Usually placed at 12-14 weeks (history-indicated) or when shortening detected (ultrasound-indicated)
  • Removal: Typically at 36-37 weeks
  • Efficacy: Reduces recurrent PTB by 30-40%

Management Algorithm:

Very Short Cervical Length (< 15 mm)

Management:

• Urgent evaluation: Immediate maternal-fetal medicine consultation
• Cerclage consideration: Strongly considered if < 24 weeks
• Activity modification: May recommend pelvic rest, decreased activity
• Corticosteroids: Consider if < 32-34 weeks and delivery likely
• Tocolytics: If uterine contractions present
• Patient counseling: Regarding risks and management options

Indications

History-Indicated Cerclage:

• Indication: Prior spontaneous preterm birth(s) attributable to cervical insufficiency
• Timing: 12-14 weeks gestation
• Criteria: Typically ≥ 1 prior PTB < 34 weeks attributable to painless cervical dilation

Ultrasound-Indicated Cerclage:

• Indication: Short cervical length (< 25 mm) on transvaginal ultrasound
• Timing: Usually before 24 weeks (most effective < 22 weeks)
• Criteria: Singleton gestation, prior PTB, and cervical length < 25 mm

Rescue Cerclage:

• Indication: Advanced cervical dilation (2-4 cm) detected on physical exam
• Timing: Before 24 weeks
• Criteria: No contractions, no infection, no ruptured membranes

Procedure and Outcomes

Procedure:

• Anesthesia: Spinal or epidural anesthesia
• Technique: Stitch (usually Mersilene tape) placed around cervix at level of internal os
• Duration: 20-30 minutes
• Recovery: Typically outpatient procedure, home same day

Success Rates:

Risks and Complications:

• Risks: Infection (1-2%), rupture of membranes (2-5%), cervical trauma (rare), preterm labor (10-15%)
• Contraindications: Active labor, ruptured membranes, intrauterine infection, significant vaginal bleeding, fetal demise, major fetal anomaly

Vaginal Progesterone

Indication:

• Short cervical length (< 20 mm) in women with no prior preterm birth
• Alternative for women with prior PTB who decline cerclage or are not candidates

Dosing and Administration:

• Dose: 200 mg daily (micronized progesterone)
• Route: Vaginal suppository or gel
• Timing: Initiated when short cervix identified (typically 18-24 weeks)
• Duration: Continue until 36-37 weeks

Efficacy:

Side Effects:

• Common: Vaginal discharge, irritation, spotting
• Less common: Nausea, headache, drowsiness
• Generally well-tolerated: Most women tolerate without significant side effects

17-OHPC (17-alpha-hydroxyprogesterone caproate)

Different from vaginal progesterone:

• Route: Intramuscular injection weekly
• Indication: Women with prior spontaneous preterm birth
• Efficacy: Reduces recurrent PTB by approximately 30%
• Note: Does not appear to be effective for short cervical length in women without prior PTB

Current Status:

• FDA approval: Withdrawn by manufacturer in 2020 (concerns about efficacy)
• Still available: Compounded preparations available
• Clinical use: Still used by some clinicians for women with prior PTB

Special Considerations:

• Higher baseline risk: Twins have 10-15% risk of PTB < 32 weeks
• Normal cervical length: Slightly longer than singletons early, similar later
• Short cervix: < 20-25 mm considered short
• Effectiveness of interventions: More controversial

Management:

Signs and Symptoms of Preterm Labor:

• Uterine contractions: Regular contractions (more than 6 per hour)
• Pelvic pressure: Feeling of pressure in pelvis or vagina
• Vaginal discharge: Change in amount or character
• Back pain: Constant low, dull backache
• Abdominal cramping: Menstrual-like cramping with or without diarrhea

Activity Modification:

• For short cervix: May recommend pelvic rest, avoiding heavy lifting, decreased sexual activity
• No bed rest: Routine bed rest not recommended (associated with thrombosis, no clear benefit)
• Individualized: Activity recommendations individualized based on situation

Does a short cervix mean I will deliver early? Not necessarily. A short cervix increases your risk of preterm birth, but it's not a guarantee. With interventions like progesterone and cerclage, many women with short cervices deliver at term or near term. The risk depends on how short the cervix is, your gestational age, and other risk factors. For cervical length 20-24 mm without prior preterm birth, approximately 10-15% deliver before 34 weeks. For cervix < 15 mm, 50-60% deliver before 34 weeks without intervention, but this can be reduced with appropriate treatment.

How accurate is cervical length measurement? Transvaginal cervical length measurement is highly accurate when performed properly by trained sonographers. Interobserver variability is generally within 2-3 mm. The measurement is more reliable than speculum or digital examination. However, proper technique is important: empty bladder, minimal pressure on the cervix, proper sagittal view, and clear landmarks. Measurements should be performed by providers experienced in the technique.

Is cervical length measurement painful? Most women find cervical length measurement mildly uncomfortable but not painful. The vaginal probe is similar in size to a tampon. The examination takes only 2-3 minutes. You may feel some pressure or mild discomfort. The examination is generally well-tolerated. Having an empty bladder and relaxing during the examination can improve comfort.

What is cerclage and is it safe? Cerclage is a stitch placed around the cervix to provide mechanical support and prevent premature opening. It's a minor surgical procedure performed under spinal or epidural anesthesia. The procedure takes 20-30 minutes and you typically go home the same day. Cerclage is generally safe, with low risks of infection (1-2%), ruptured membranes (2-5%), and rare cervical trauma. The benefits generally outweigh the risks for women with prior preterm birth and a short cervix, as it reduces recurrent preterm birth by 30-40%.

Do I need to be on bed rest if my cervix is short? No, routine bed rest is not recommended for short cervix. Bed rest doesn't prevent preterm birth and can actually increase your risk of blood clots, bone loss, muscle weakness, and financial/emotional stress. Your doctor may recommend activity modification (avoiding heavy lifting, decreasing strenuous activity, sometimes pelvic rest), but complete bed rest is not recommended. Stay active within comfort limits while following your provider's specific recommendations.

• Transvaginal cervical length measurement between 18-24 weeks is the gold standard for assessing preterm birth risk, with normal length > 25 mm and short cervix defined as < 25 mm.

• Universal screening of all pregnant women is recommended by ACOG, as the majority of preterm births occur in women without prior preterm birth and effective interventions exist when short cervix is identified.

• Spontaneous preterm birth risk increases dramatically with decreasing cervical length: < 1% for length > 30 mm, 10-15% for 20-24 mm, 25-40% for < 20 mm, and 50-60% for < 15 mm.

• Vaginal progesterone (200 mg daily) reduces preterm birth < 34 weeks by 40-45% in women with short cervix (< 20 mm) and no prior preterm birth, and is continued until 36-37 weeks.

• Cervical cerclage reduces recurrent preterm birth by 30-40% in women with prior preterm birth and cervical length < 25 mm, with history-indicated cerclage placed at 12-14 weeks and ultrasound-indicated cerclage placed when shortening detected.

• Management is individualized based on cervical length, gestational age, prior obstetric history, and presence of other risk factors, with serial measurements every 2-4 weeks indicated for high-risk women.

• The examination takes 2-3 minutes, is generally well-tolerated with minimal discomfort, requires an empty bladder for accuracy, and has high interobserver reliability when performed by trained sonographers.

• In multiple gestation, cervical length assessment is recommended but effectiveness of interventions is less clear, with management individualized based on specific circumstances.